| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.2M | -6.7% | -13.3% |
| Cost of Revenue | $15.2M | -5.7% | -6.2% |
| Gross Profit | $11.0M | -8.2% | -21.6% |
| R&D Expense | $2.3M | +4.0% | +7.0% |
| SG&A Expense | $5.1M | -11.0% | -27.4% |
| Operating Income | -$1.2M | -28.7% | -345.0% |
| Pre-tax Income | -$1.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.2M | -15.7% | -9.7% |
| Accounts Receivable | $20.9M | -10.5% | -26.3% |
| Inventory | $28.0M | +1.4% | -11.6% |
| Current Assets | $75.1M | +0.3% | -7.5% |
| Total Assets | $148.3M | -0.9% | -6.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.3M | — | — |
| Capital Expenditures | $1.1M | — | — |
| Investing Cash Flow | -$1.1M | — | — |
| Financing Cash Flow | -$6.8M | — | — |
| Free Cash Flow | $7.2M | — | — |
| -110.5% |
| -315.6% |
| Income Tax | -$289K | -261.3% | -490.5% |
| Net Income | -$938K | -86.5% | -289.5% |
| EPS (Basic) | -$0.08 | -100.0% | -300.0% |
| EPS (Diluted) | -$0.08 | -100.0% | -300.0% |
| $32.4M |
| +4.8% |
| -9.7% |
| Long-term Debt | $4.9M | -17.4% | -45.7% |
| Total Liabilities | $46.4M | -1.4% | -20.0% |
| Stockholders' Equity | $101.9M | -0.7% | +1.5% |